Brief: Sol Gel Technologies Q2 Revenue $1.1 Million
Aug 6 (Reuters) - Sol Gel Technologies Ltd SLGL.O :
* SOL-GEL TECHNOLOGIES REPORTS SECOND QUARTER 2020 FINANCIAL
RESULTS AND CORPORATE UPDATE
* Q2 REVENUE $1.1 MILLION
* Q2 REVENUE ESTIMATE $3.1 MILLION -- REFINITIV IBES DATA
* NEW DRUG APPLICATION FOR EPSOLAY SUBMITTED; TWYNEO NEW
DRUG
APPLICATION ON TRACK FOR 2H 2020
* QTRLY LOSS PER ORDINARY SHARE OF $0.31
Source text for Eikon: ID:nGNX7yms1k
Further company coverage: SLGL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SOL-GEL TECHNOLOGIES
See all newsIsraeli dermatology firm Sol-Gel's Q2 revenue drops sharply on prior-year IP sale
SOL-GEL TECHNOLOGIES LTD. expected to post a loss of $2.57 a share - Earnings Preview
Sol-Gel Q1 revenue falls sharply on milestone payment impact
Brief: Sol-Gel Technologies Ltd. Q1 Revenue USD 100 Thousand
Brief: Sol-Gel Technologies Ltd. Announces Pricing Of Oversubscribed Underwritten Offering